204 related articles for article (PubMed ID: 1528208)
21. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Eisenberg PR; Miletich JP
N Engl J Med; 1995 Apr; 332(14):912-7. PubMed ID: 7877648
[TBL] [Abstract][Full Text] [Related]
22. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
[TBL] [Abstract][Full Text] [Related]
23. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
[TBL] [Abstract][Full Text] [Related]
24. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
[TBL] [Abstract][Full Text] [Related]
25. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G
N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538
[TBL] [Abstract][Full Text] [Related]
26. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
[TBL] [Abstract][Full Text] [Related]
27. Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis.
Prandoni P; Lensing AW; Büller HR; Carta M; Vigo M; Cogo A; Cuppini S; ten Cate JW
Thromb Haemost; 1991 Mar; 65(3):233-6. PubMed ID: 2048047
[TBL] [Abstract][Full Text] [Related]
28. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
Heijboer H; Brandjes DP; Büller HR; Sturk A; ten Cate JW
N Engl J Med; 1990 Nov; 323(22):1512-6. PubMed ID: 2146503
[TBL] [Abstract][Full Text] [Related]
29. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
30. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis.
Martinelli I; Bucciarelli P; Passamonti SM; Battaglioli T; Previtali E; Mannucci PM
Circulation; 2010 Jun; 121(25):2740-6. PubMed ID: 20547928
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.
Imberti D; Agnelli G; Ageno W; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
Haematologica; 2008 Feb; 93(2):273-8. PubMed ID: 18223291
[TBL] [Abstract][Full Text] [Related]
32. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
33. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
Pengo V; Lensing AW; Prins MH; Marchiori A; Davidson BL; Tiozzo F; Albanese P; Biasiolo A; Pegoraro C; Iliceto S; Prandoni P;
N Engl J Med; 2004 May; 350(22):2257-64. PubMed ID: 15163775
[TBL] [Abstract][Full Text] [Related]
34. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N
N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777
[TBL] [Abstract][Full Text] [Related]
35. [Incidence of cancer after primary deep venous thrombosis or pulmonary embolism].
Sørensen HT; Mellemkjaer L; Steffensen FH; Olsen JH; Nielsen GL
Lakartidningen; 2000 Apr; 97(16):1961-4. PubMed ID: 10826355
[TBL] [Abstract][Full Text] [Related]
36. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
[TBL] [Abstract][Full Text] [Related]
37. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
38. Incidence of venous thromboembolism in patients hospitalized with cancer.
Stein PD; Beemath A; Meyers FA; Skaf E; Sanchez J; Olson RE
Am J Med; 2006 Jan; 119(1):60-8. PubMed ID: 16431186
[TBL] [Abstract][Full Text] [Related]
39. [Thromboembolic venous disease as a first sign of neoplastic disease--a case report].
Drosik A; Trzepióra B; Kozielski J
Wiad Lek; 2012; 65(1):15-8. PubMed ID: 22827111
[TBL] [Abstract][Full Text] [Related]
40. Deep vein thrombosis and occult cancer.
Prandoni P
Ann Med; 1993 Oct; 25(5):447-50. PubMed ID: 8251143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
